Skip to search form
Skip to main content
Create Free Account
You are currently offline. Some features of the site may not work correctly.
National Institutes of Health
daclatasvir 30 MG Oral Tablet [Daklinza]
Semantic Scholar uses AI to extract papers important to this topic.
China FDA Approves Country ’ s First All-Oral Regimen for Chronic Hepatitis C , Daklinza ® ( daclatasvir ) in Combination with Sunvepra ® ( asunaprevir )
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that the China Food and Drug…
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Terms of Service
ACCEPT & CONTINUE